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Background: Antibiotic resistance is one of the most serious public health concerns worldwide and is increasing at
an alarming rate, making daily treatment decisions more challenging. This study is aimed at identifying local
bacterial isolates and their antimicrobial susceptibility patterns to avoid irrational antibiotic use, especially in settings
where unguided management occurs and febrile illnesses are predominant.
Material and methods: A hospital-based prospective cross-sectional study was conducted from September 2011 to
February 2012. Febrile children were serially recruited and demographic and clinical data were collected using a
standardized data collection tool. A blood culture was performed and identification of the isolates was undertaken using
in-house biochemical tests. Susceptibility to common antibiotics was investigated using the disc diffusion methods.
Results: Of the 1081 children admitted during the study period, 317 (29.3%) met the inclusion criteria and were
recruited, of whom 195 (61.5%) and 122 (38.5%) were male and female respectively. The median age was 18 months
with an interquartile range of 9 to 36 months. Of the 317 children, 251 (79.2%) were below or equal to 36 months of
age. The prevalence of bacteremia was 6.6%. A higher prevalence of bacteraemia was observed in children below
36 months than in those≥ 36 months (7.5% vs. 3.0%, p = 0.001). Predictors of bacteraemia were an axillary temperature
of >38.5 °C (OR =7, 95% CI = 2.2 - 14.8, p-value = 0.0001), a positive malaria slide (OR =5, 95% CI = 3.0 - 21.2,
p-value = 0.0001) and a high neutrophils’ count (OR =21 95% CI = 5.6 - 84, p-value = 0.0001). Escherichia coli and
Klebsiella pneumoniae accounted for 7 (33.3%) and 6 (28.6%) of all the isolates respectively. Others
gram-negatives bacteria were Citrobacter spp 2 (9.5%), Enterobacter spp 1 (4.25%), Pseudomonas spp 2 (9.5%), Proteus
spp 1 (4.25%) and Salmonella spp 1 (4.25%). These isolates were highly resistant to ampicillin (95%), co-trimoxazole
(90%), tetracycline (90%), gentamicin (80%), augmentin (80%), chloramphenicol (65%), ceftriaxone (35%), cefotaxime
(35%) ciprofloxacin (30%), amikacin (30%), ceftazidime (25%) and norfloxacine (10%).
Conclusion: Multi-resistant gram-negative bacteria are the commonest cause of bacteremia in under-fives attending
the Bugando Medical Centre, Mwanza, Tanzania. A high body temperature, a positive malaria slide and a high absolute
neutrophils’ count were all independent risk factors found to predict bacteremia. A higher mortality rate was observed
in children with bacteraemia. Continuous epidemiological surveillance should be conducted so that a proper and
effective antibiotics management can be instituted, especially in children with a high grade fever, a positive malaria
slide and a high neutrophils’ count.Background
Febrile illnesses remain the leading cause of morbidity
and mortality among children, especially in Sub-Saharan
Africa [1,2]. The World Health Organization (WHO)
defines febrile illness as an acute illness characterized by
a rise in body temperature. Viral infections, bacteremia* Correspondence: mshana72@yahoo.com
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distribution, and reproduction in any mediumand malaria are among the commonest causes of these
febrile illnesses in the developing countries [3]. Moreover,
a high mortality rate is associated with bacteraemia. A
study done at the Muhimbili National Hospital in
Tanzania reported a mortality of 40% in pediatric patients
with laboratory confirmed bacteremia [4]. Worldwide,
76% (4.6 million) of the underfives deaths occur due to
undiagnosed invasive bacterial infections (http://www.
unicef.org/publications/files/2004_OfficialSumm_ENG.pdf).
In malaria endemic areas, 11% of the children admittedntral Ltd. This is an Open Access article distributed under the terms of the
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(12%) of those children will die because malaria was
over diagnosed at the expense of other causes of fever [5].
Moreover, bacterial culture to diagnose bacterial infection
is not routinely done in most of the primary and
secondary health facilities. This leads to unguided empirical
treatment with antibiotics, which, in turn, may result into
an increase of antimicrobial resistance [6].
Varieties of bacteria have been found to cause febrile
illnesses in children. These include Staphylococcus spp,
Streptococcus spp, Enterobacter spp, Escherichia coli,
Klebsiella pneumoniae, Pseudomonas spp, Enterococcus
spp, Neisseria meningitides, Salmonella spp, Moraxella
catarrhalis, Haemophilus influenzae and Campylobacter
spp [7-9]. The WHO claims that inadequate access to
appropriate near-patient diagnostic tools can also be a
driving factor for prescribing antibiotics when not clearly
indicated [10]. The findings from this study will contribute
to a proper implementation of the guided empirical
treatment of common bacteria isolates causing febrile
illnesses in our setting. Predictors of positive blood culture
and of in-hospital mortality are crucial to clinicians to
ensure a timely and appropriate management response.Methods
This was a hospital-based prospective cross-sectional study
including 317 children aged 2 to 60 months admitted at
the Bugando Medical Centre (BMC) general pediatric
ward. A total of 80% of the children were referred from
other health facilities in the Lake Zone, North_Western
Tanzania, during the study period (September 2011 to
February 2012). Children enrolled in the study were
those aged between 2–60 months with an axillary
temperature ≥ 37.5 °C at the time of admission. Children
with a history of antibiotics’ use in the past 24 hours
were also included into the study. All children included
in the study had informed parent/guardian consent.Sample size estimation and sampling
The sample size was calculated by the double proportional
formula for predictors using STATA version 11. The two
proportions used were based on studies undertaken at the
General Pediatric wards, Kenyatta National Hospital,
Nairobi, Kenya [11] which showed a 13.2% prevalence of
bacteremia among children without malaria, and in
Boston, Massachusetts, USA, which looked into fever as a
predictor of bacteremia and found the prevalence to be
4% [12]. The minimum sample size required was 270
patients but the study enrolled 317 patients. All children
aged between 2 to 60 months attending the Bugando
Medical Centre were serially recruited until the sample
size was reached.Sample collection and laboratory procedures
Two blood specimens from the same venepuncture were
collected from all enrolled children. The child’s skin was
cleaned with 70% ethanol and allowed to dry before
blood was drawn for culture and other investigations. For
the blood culture, the ratio of blood: Brain Heart Infusion
broth (Oxoid UK) was 1:10. Two bottles of Brain
Heart Infusion broth with the collected blood specimen
were transported to the laboratory and incubated for
18–24 hours at 37°C aerobically. The specimens were
sub-cultured on blood, MacConkey and chocolate agar,
as previously described [13]. For positive blood cultures,
the isolates were identified according to conventional
physiological and biochemical methods [13,14]. The
antimicrobial susceptibility patterns of all isolates were
determined by the disc diffusion method according to the
Clinical Laboratory Standards Institute [15]. Antimicrobial
susceptibility patterns for gram negative bacteria were
ampicillin, gentamicin, norfloxacin, amoxicillin/clavulanic
acid, co-trimoxazole, chloramphenicol, ceftriaxone, cefta-
zidime and meropenem. All isolates resistant to third
generation cephalosporin were tested for Extended
Spectrum Beta-Lactamases (ESBL) production using
the disk approximation method. To determine ESBL
production, ceftazidime (30 μg) and cefotaxime (30 μg)
discs were placed equidistant from the amoxycillin/
clavulanate (20/10 μg) disc; an enhanced zone of inhibition
towards amoxycillin/clavulanate (20/10 μg) disc was
considered as a positive result for ESBL production
[16,17]. The Bugando Medical Centre laboratory is
participating in a bacteriology external quality assurance
coordinated by a reference laboratory in South Africa
(WHO/NICD). For the quality control of the media, discs
and incubation conditions, we used Escherichia coli
ATCC 25922, Streptococcus pneumoniae ATCC 49619
and Staphylococcus aureus ATCC 25923. Total white
blood cells and neutrophils’ counts were determined
using a haematology analyzer (Beckman Coulter (UK)
Ltd). HIV and malaria were diagnosed as previously
described [18,19].
Data analysis
Data collected were entered into a computer using
EpiData version 3.1 (CDC, Atlanta, USA) according to
codes given, and analyzed using the STATA version 11
(College Station, Texas, USA). Categorical variables were
summarized as proportions and were analyzed using the
Pearson’s Chi-square test to observe the differences
among the various groups. Continuous variables were
summarized as mean or median and were analyzed using
the student t-test or Wilcoxon-Mann–Whitney test
where appropriate. Univariate analysis and multivariate
logistic regression models were fitted to determine the
predictors of culture positivity and in-hospital mortality.
1081 children admitted at BMC 
between September 2011 to   
February 2012
317 underfives met inclusion 
criteria : Blood culture, full blood 
picture and blood slides were 
done
Following children were excluded:
281 aged < 2 months 
197 aged > 60 months
131 used antibiotics more than 
48 hours
66 children  mothers did not
consent 
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Figure 1 Flow chart showing children studied and magnitude of different outcome.
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http://www.ijponline.net/content/39/1/27Predictors with p-value less than 0.2 were fitted into the
multivariate logistic regression analysis and their odds
ratios and 95% confidence interval were noted. Predictors
with p-value of less than 0.05 were considered statically
significant. Dependent variables included bacteremia and
in-hospital mortality while independent variables were
the clinical presentation, the laboratory findings and
the socio-demographic characteristics of the patient.
The study was approved by the BMC/CUHAS ethics
committee and parents/caretakers were asked to sign an






















During the study period between September 2011 and
February 2012, a total of 1081 infants and children were
admitted to the BMC paediatric ward. A total of 317
(40.6%) met the inclusion criteria and were studied
(Figure 1). Of these, 195(61.5%) were male. The median
age was 18 months with an interquartile range of 9 to 36
(Table 1). All children recruited in this study received
vaccines as recommended by the Tanzania Immunization
Programme. Vaccines provided by the programme include
the BCG and OPV 0 at birth; the OPV-1 and DPTHB-Hib
1 at 4 week; the OPV-2 and DPTHB-Hib 2 at the 8th
week, and the OPV-3, DPTHB-Hib 3 at the 12th week.
The measles vaccine is provided at 9 months.
The prevalence of bacteremia in the present study
was 6.6%. Most of the children with bacteremia had
an age less than or equal to 36 months (7.5% vs.
3.0%, p > 0.05). Ten blood cultures (3.2%) showed
growth in only one bottle on the first culture and all
were negative on repeat blood culture. These were
regarded as contaminants and, since they may have
masked a true infection, the respective patients were
excluded from the analysis. All contaminants were
coagulase negative Staphylococci.Bacteria isolates and antimicrobial susceptibility pattern
During the study, common bacteria isolated were
Escherichia coli and Klebsiella pneumoniae, which
accounted for 7 (33.3%) and 6 (28.6%) of total isolates
respectively. Others gram-negatives isolated were
Citrobacter spp 2 (9.5%), Enterobacter spp 1 (4.25%),
Christopher et al. Italian Journal of Pediatrics 2013, 39:27 Page 4 of 8
http://www.ijponline.net/content/39/1/27Pseudomonas aeruginosa 2 (9.5%), Proteus spp 1 (4.25%)
and Salmonella spp 1 (4.25%). Only one isolate was
gram-positive bacteria and was identified as Staphylococcus
aureus. Gram-negative enteric bacteria were resistant to
most of the antibiotics tested, including ampicillin (95%),
co-trimoxazole (90%), tetracycline (90%), gentamicin (80%),
augmentin (80%), chloramphenicol (65%), ciprofloxacin
(30%), amikacin (30%), ceftazidime (25%), ceftriaxone
(35%), cefotaxime (35%) and norfloxacin (10%) (Table 2).
Twenty seven percent of the gram-negative enteric
bacteria were found to produce extended spectrum beta
lactamase (ESBL) using the disk approximation method.
Predictors of bacteremia
An axillary temperature >38.5°C (OR =7, 95% CI = 2.2 -
14.8, p-value = 0.0001), a positive malaria blood slide
(OR =5, 95% CI = 3.0 - 21.2, p-value = 0.0001) and a
high neutrophils’ count (OR =21 95% CI = 5.6 - 84,
p-value = 0.0001) were found to be predictors of bacteremia
on both univariate and multivariate logistic regression
(Table 3). A neutrophils’ count of more than 10,000 cells/
liter was defined as high. Children with bacteremia
had significantly higher counts of total WBC thanTable 2 susceptibility pattern of 20 gram negative isolates fro
NO ISOLATE G CIP TET AK AMC
99 Escherichia coli R S R S S
119 Escherichia coli S R R S R
212 Escherichia coli R S R S R
237 *Escherichia coli R R R S R
253 Escherichia coli S S R S S
275 Escherichia coli R S R S R
300 Escherichia coli R R R S R
28 K. pnuemoniae R R R R R
50 K. pnuemoniae R S R R R
101 *K. pnuemoniae R S R R R
189 *K. pnuemoniae R R R S R
255 K. pnuemoniae R S R R R
215 K. pnuemoniae R S R R R
12 P.aeuriginosa R S R S R
148 P.aeuriginosa R R R R R
21 Enterobacter spp S S S S R
108 Salmonella spp S S S S S
191 *Citrobacter spp R S R S R
250 *Citrobacter spp R S R S R
5 Proteus spp R S R S R
60 S. aureus R R R S R
A; ampicillin, AMC; amoxyillin/clavunate, CIP; ciprofloxacin, TET; tetracycline, G; gen
ceftazidime, AK: amikacin, MEM; meropenem, NO; Norfloxacin, C; chloramphenicol
applicable, S: Inducible resistance is expected. S; Salmonella spp may test susceptib
cefoxitin and oxacillin and found to be sensitive so it is not MRSA.those without bacteremia, with a median of 16.1
versus 9.1 respectively (Wilcoxon-Mann–Whitney test,
p-value = 0.0001) (Table 4). Furthermore, children with
bacteremia had significantly lower levels of hemoglobin
than those without bacteremia, with a mean of 7.4 g/dl
versus 8.4 g/dl respectively (student t-test, p-value 0.04).
Of all the children enrolled into the study, 9/317 (2.8%)
died; of those, 2/21 (9.5%) children had bacteremia and
7/296 (2.4%) did not have bacteremia. By multivariate
logistic regression analysis, bacteremia was found to be
a statistically significant predictor of in-hospital mortality.
(OR = 6, 95% CI = 1.8-4.4) and P = 0.04).
Discussion
The underfives enrolled in the present study were between
2 months and 60 months old. The age category of
this study is in keeping with most of the studies
done elsewhere in the world, as the children infections
preventable by vaccination are prevalent before five years
of age [20-22]. Of the enrolled patients, 61.5% were male,
which was similar to the study done in Uganda and
Malawi were male constituted 63 and 57 percent of the
total children respectively [23,24]; this also matched them febrile children (N = 317)
NO C SXT A CZA CRO CTX MEM
S R R R S S S S
S S R R S S S S
S R R R S S S S
R S R R R R R S
S R R S S S S S
S R R R S S S S
S R R R S S S S
S R R R S S S S
S R R R S S S S
S R R R R R R S
S R R R R R R S
S R R R S S S S
S R R R S S S S
S R R R R NA NA S
R R R R S NA NA S
S S R R S S S S
S S S R S S S S
S S R R R R R S
S S R R R R R S
S S R R S S S S
S R R R NA NA NA S
tamicin, SXT; sulfamethoxazole/ trimethoprim, CRO; ceftriaxone, CAZ;
and CTX; Cefotaxime. R; resistant, S; sensitive. * ESBL producer, NA; Not
le in vitro but the drug is ineffective in vivo. Isolate no 60 was tested with
Table 3 Showing predictors of bacteremia
Predictive factor Bacteremia Univariate Multivariate
YES n = 21 NO n = 296 OR (95%CI) P-value OR (95% CI) P-value
Temperature
≤38.5°C 6 (2.6) 225 (97.4) 1
>38.5°C 15 (17.4) 71 (82.6) 7.9 (2.9-21.2) 0.0001 13 (3.5-54) 0.0001
Lethargic
No 17 (6.5) 244 (93.5) 1
Yes 4 (7.1) 52 (92.9) 1.1 (0.4-3.4) 0.86 - -
Dehydration
No 18 (8.1) 204 (91.9) 1
Yes 3 (3.2) 92 (96.8) 0.4 (0.1-1.3) 0.12 0.9 (0.2-3.9) 0.8
Pneumonia
No 16 (6.2) 244 (93.8) 1
Yes 5 (8.7) 52 (91.3) 1.5 (0.5-4.2) 0.48 - -
Convulsions
No 16 (5.8) 260 (94.2) 1
Yes 5 (12.2) 36 (87.8) 2.2 (0.7-6.5) 0.13 1.3 (0.3-5.8) 0.7
Neck stiffness
No 20 (6.6) 282 (93.4) 1
Yes 1 (7.7) 12 (92.3) 1.2 (0.2-9.5) 0.88 - -
Antibiotics use for less than 24 hrs
No 7 10.0) 63 (90.0) 1
Yes 14 (5.7) 231 (94.3) 0.6 (0.2-1.4) 0.21 - -
Positive Blood slide for malaria parasite
No 7 (3.2) 212 (96.8) 1
Yes 13 (15.8) 69 (84.2) 5.7 (2.2-14.8) 0.0001 14 (3.5-60) 0.0001
Sickle cell disease
No 15 (5.5) 259 (94.5) 1
Yes 6 (13.9) 37 (86.1) 2.8 (1.0-7.7) 0.04 1 (0.3-4.4) 0.9
Malnutrition
No 19 (7.4) 238 (92.6) 1
Yes 2 (3.3) 58 (96.7) 0.4 (0.1-1.9) 0.26 - -
Neutrophils
≤10000 c/l 6 (2.4) 245 (97.6) 1
>10000 c/l 15 (26.3) 42 (73.7) 14 (5.4-39.7) 0.0001 21 (5.6-84) 0.0001
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the under-fives presented with malnutrition. This figure
was lower than the one reported in the study undertaken
in Kilifi, Kenya, which quoted a prevalence of malnutrition
of 25% [22]. A total of 13.6% under-fives had sickle cell
disease at the time of admission which was higher than
the result shown in a study done in Central Nigeria, in
which only 6% of children had sickle cell disease [25]. The
higher prevalence found in this context may be due to an
over diagnosis of the disease, as hemoglobin electrophoresis
is not routinely done to confirm sickle cell disease.The prevalence of bacteremia among children admitted
with fever was 6.6%. A study undertaken at the Muhimbili
National Hospital (Tanzania) reports a prevalence of
13.9% [4]. The difference between the results could be
explained by the fact that the Muhimbili study enrolled
children aged 0 to 7 years and that the BACTEC MYCO/
F LYTIC method for blood culture was used. This method
supports the growth of fungi and fastidious bacteria
including mycobacterium [4,26]. The prevalence of
bacteremia in the present study was also lower than the
one found by previous studies done in Mwanza and








Total WBC c/l *103 16.1 (11–21.8) 9.1 (5.7-13.5) 0.0001
Lymphocytes c/l 2990 (2178–4379) 2522.5 (190–5130) 0.3935
Thrombocytes *109/l 397 (226.5-529) 370 (242–507) 0.7374
*Hemoglobin g/dl *7.4 ± 2.6 *8.4 ± 2.6 0.04
* For hemoglobin the mean ± Standard Deviation.
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20.7% respectively [19,25]. This could be explained by the
fact that under-fives involved in both studies were coming
directly from home, hence the use of antibiotics may have
been minimal. The prevalence in our study is comparable
to the study done in Kilifi, Kenya which documented
a prevalence of 6% [22]. As this was a six-month
cross-sectional study, seasonal variations of bacteraemia
could not be addressed.
In the present study, the majority of bacteria isolated
from the blood were gram-negative. Of these gram-negative
bacteria, Escherichia coli and Klebsiella pneumoniae were
the commonest isolates. Others gram-negatives included
Citrobacter, Enterobacter spp, Pseudomonas aeruginosa
and Proteus spp. This is contrary to others studies
which reported the commonest isolate to be Streptococcus
pneumoniae, Neisseria meningitidis, Haemophilus influenza
b and Group A Streptococci [4,8]. The difference could
be explained by the ongoing implementation in our setting
of an extensive under-five immunization programme in-
cluding the vaccination against Haemophilus influenza b.
The failure to isolate Streptococcus pneumoniae in our
study could be due to self-prescription of ampicillin by
patients in the community and/or to the prescription
at health facilities where no routine blood culture is
undertaken. It could also be due to the particular technique
used in the present study. However, during the study
period, Streptococcus pneumoniae isolates were isolated
from the blood of HIV infected adults admitted in medical
wards using the same blood culture techniques and the
Streptococcus pneumoniae ATCC 49619 was used to
quality control the media and incubation conditions.
These facts minimize therefore the possibility of a technical
problem.
The number of isolates in this cohort was too small to
establish local susceptibility patterns but has provided
baseline data and has stimulated the surveillance of
isolates involved in blood stream infections in our setting.
The gram-negative bacteria were multiply-resistant to
ampicillin, co-trimoxazole, tetracycline, gentamicin, amoxi-
cillin/clavulanate and chloramphenicol, which are locally
available antibiotics. Almost all isolates were resistant toampicillin and sulphamethaxazole/trimethoprim, which
are commonly self-prescribed in the local communities
[18]. Of 317 children, 247 (78%) were referred from
peripheral health facilities so the resistance patterns could
reflect hospital-acquired infections. However, due to a high
resistance of Escherichia coli and Klebsiella pneumoniae to
antibiotics commonly used by the community, as described
by Msaki et al. [18], community-acquired resistance is also
a possibility. The susceptibility patterns are similar to the
findings reported by Muhimbili and Mwanza in Tanzania
and Mozambique, which found that the majority of
Escherichia coli, Klebsiella pneumoniae and Salmonella
spp were resistant to gentamicin, chloramphenicol and
Sulphamethaxazole/trimethoprim [4,27-29].
This study showed that a high body temperature,
malaria and a high absolute neutrophils count were strong
predictors of bacteremia. The study findings are similar
to those previously reported [20,30,31]. The strong associ-
ation between malaria and bacteremia demonstrated in
this study concurred with the studies undertaken in Kenya
and Malawi [22,24,32]. In contrast to previous studies,
HIV was not found to predict bacteremia. This could be
explained by the low prevalence of HIV infection among
the group of children studied.
In the current study, the mortality rate was 2.8% and
was strongly predicted by bacteremia. The presence of
gram-negative bacteria might have contributed to the
risk of death. As a matter of fact, a study done at
the Muhimbili National Hospital inTanzania reported a
mortality rate from gram-negative bloodstream infections
more than the double of the one due to malaria and
gram-positive bloodstream infections [4]. The mortality
rate observed in the present study is lower than the one
observed in other African countries such as Kenya, Zaire
and Malawi [33-35]. It is also lower than the one previously
reported at the Muhimbili National Hospital [4]. These
results could be explained by the empirical treatment
practiced at the Bugando Medical Centre (BMC), whereby
children admitted were all given a second line treatment
(third generation cephalosporins) though about 78% of
them had already received antibiotic treatment at the per-
ipheral health facilities before being referred to the BMC.
Among the deaths, only two patients had bacteremia
due to Pseudomonas aeruginosa and one had malnutri-
tion and co-infection with malaria. The two isolates of
Pseudomonas aeruginosa were resistant to the commonly
used antibiotics, i.e. first line empirical treatment, which
is ampicillin and gentamicin and second line empirical
treatment, which is third generation cephalosporins.
The third line empirical treatment in our setting is
meropenem but is often not available and, if available, is
too expensive for the patients to afford. The cause of
mortality was in keeping with a study done in the
Gambia which found that significant risk factors for
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and malnutrition [36].
Recall bias on symptoms and failure to perform antibi-
otics assay in body fluid and investigations of other causes
of fever were the major limitations of this study. Prior
antibiotic use due to self-prescription and prescription
from other health care facilities may have affected the
blood culture yield.Conclusion
A high axillary temperature, a positive malaria slide and
a high absolute neutrophils’ count are independent risk
factors for bacteremia among under-fives in our setting.
Furthermore, most of the bacteria isolated from blood
among underfives are multiply-resistant gram-negative
enteric bacteria. Of all the factors under investigation,
bacteremia was found to be a strong predictor of death
among underfives. A large community- and hospital-based
epidemiological surveillance should be conducted so
that a proper and effective management of antibiotics is
instituted, especially in the treatment of under-fives
with a high grade fever, a positive malaria slide and a
high neutrophils count. Our findings also emphasize the
urgent need for surveillance data to monitor the resistance
trends to commonly used antibiotic and third generation
cephalosporins. Infection prevention strategies and anti-
microbial stewardship to contain the further multiplication
and spread of antimicrobial resistance should also be
considered. It should be clearly understood that an
increased use of third generation cephalosporins can
result in a worsening of the situation. Third generation
cephalosporins should be preserved, for as long as
possible, with antimicrobial stewardship to reserve their
use exclusively for patients where first-line therapy has
failed. Moreover, the infection control to prevent spread
of ceftriaxone -resistant organisms from one patient to
another can reduce their use. The implementation of the
lessons learned from third generation cephalosporins will
allow the rational management of carbapenems when they
will become readily available in developing countries and
will prevent carbapenemases to become as rampant as
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